Sustainable Development Goals
Integrating care and climate adaptation into a holistic fiscal framework at the country level
On February 23, the Engelberg Center for Health Care Reform convened the third meeting on the topic of improving patient medication information (PMI). While previous discussions focused on the content and format of the single-page PMI document, this meeting focused on the process of delivering PMI to patients, a process that currently is both inconsistent and unreliable. Several independent groups presented outlines for potential distribution pilots and experts commented on pilot design, implementation of pilots, and proposed strategies to evaluate distribution through pilots. These pilots will test distribution of PMI for real products to real patients.
Discussion specifically focused on:
- What researchers have learned about how medication information is currently distributed, particularly within the current pharmacy work-flow
- Types of medical products that would be suitable for pilots
- How to create accompanying PMI prototypes
- What the community can hope to learn from such pilots
- Appropriate metrics for evaluating the distribution process
Agenda
-
February 23
-
Welcome, Overview, and Meeting Objectives
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke University -
FDA Perspectives: Past and Future for PMI
-
Session I: Goals and Objectives of PMI Distribution Pilots
-
Session II: Developing PMI for Use in Pilots
-
Session III: Potential Distribution Pilots
-
Moderated Discussion
-
Closing Remarks
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke University
-
